Theriva Biologics Inc (TOVX)
AMEX
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -102.188 | -107.103 | -103.273 | -67.866 | -97.929 | -58.874 | -28.159 | -28.878 |
Return on Equity (%) | -315.963 | 3813.264 | -470.574 | -245.398 | 292.125 | -80.144 | -34.161 | -41.33 |
Return on Invested Capital (%) | -456.021 | 4349.793 | -152.798 | -82.663 | -121.684 | -40.425 | -30.889 | -45.385 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.015 | -0.022 | 0.459 | 0.145 | 0.047 | 0.405 | 0.669 | 0.303 |
Earnings Per Share | -0.186 | -0.14 | -0.561 | -0.347 | -0.213 | -0.143 | -0.448 | -0.391 |
Cash Per Share | 0.13 | 0.108 | 0.642 | 0.324 | 0.106 | 0.417 | 0.935 | 0.493 |
Working Capital Per Share | 0.012 | 0.052 | 0.58 | 0.24 | 0.084 | 0.404 | 0.861 | 0.44 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.189 | -0.098 | -0.298 | -0.332 | -0.172 | -0.088 | -0.472 | -0.425 |
EBITDA Per Share | -0.189 | -0.098 | -0.298 | -0.332 | -0.172 | -0.088 | -0.472 | -0.425 |
Free Cash Flow Per Share | -0.183 | -0.14 | -0.567 | -0.352 | -0.217 | -0.144 | -0.447 | -0.389 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 117,17M | 128,57M | 15,48M | 16,81M | 29,25M | 132,04M | 15,12M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 15,12M | N/A | 17,04M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 4,9M |
Ratio cours/bénéfice | -0,22 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,17 |
Ratio prix/valeur comptable | 0,1 |
Rendement de dividende | - |
Actions en circulation | 2,78M |
Volume moyen (1 semaine) | 4,25M |
Volume moyen (1 mois) | 1,03M |
Variation sur 52 semaines | -85,49% |
Plus haut sur 52 semaines | 17,1125 |
Plus bas sur 52 semaines | 1,14 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales